Market Research Report
A-Share Listed Pharmaceutical Companies - Profiles and Financial Data
|Published by||China Research and Intelligence||Product code||494479|
|Published||Content info||650 Pages
Delivery time: 1-2 business days
|A-Share Listed Pharmaceutical Companies - Profiles and Financial Data|
|Published: April 6, 2017||Content info: 650 Pages||
With growing Chinese economy and increasing residents' income, people's purchasing power of pharmaceuticals has been enhanced. China's aging population also promotes demand for pharmaceuticals. In 2016, revenues from main businesses of China's pharmaceutical industry reached CNY 2,963.59 billion, up by 9.9% YOY; profits were CNY 321.64 billion, up by 15.6% YOY. Among sub-industries, active pharmaceutical ingredients (API), pharmaceutical preparations and medical devices maintained strong profitability, witnessing their profits grow by 25.9%, 16.8% and 32.3%, respectively. The revenues from main businesses of pharmaceutical preparations, TCM decoction pieces processing, sanitary materials & medical products and medical devices industries were higher than average and grew by 10.8%, 12.7%, 11.5% and 13.3%, respectively.
In 2016, the revenue of the chemical pharmaceutical industry reached CNY 1,256.96 billion, up by 9.9% YOY; profits were CNY 139.57 billion, up by 19.6% YOY; export delivery value was CNY 79.26 billion, up by 4.5% YOY. The operating revenue of API manufacturers totaled to CNY 503.49 billion, up by 8.4% YOY; profits were CNY 44.53 billion, up by 25.9% YOY; export delivery value was CNY 64.87 billion, up by 7.4% YOY.
CRI expects that in the next few years, demand for pharmaceuticals will rise with increasing residents' income, upgrading consumption, aging population, accelerating urbanization and improving healthcare system, promoting the development of China's pharmaceutical industry.
In this report, CRI analyzes 161 pharmaceutical enterprises listed in A-share market in China.
The report is composed of two parts: the first part is enterprise profiles and the second part is the operation status of these enterprises in the recent decade (presently 2006 to 2016, we will update it to the latest as time goes by).
The operation status is demonstrated from the following perspectives: (1)financial indexes, such as earnings per share, book value per share (BPS), sales per share, net cash flow per share, return on net worth and debt to asset ratio; (2) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (3) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (4) indexes on the balance sheet, such as liquid asset, fixed asset, current liability, non-current liability, capital reserve and shareholders' equity.